Logo image of CLDI

CALIDI BIOTHERAPEUTICS INC (CLDI) Stock Analyst Earnings Estimates

NYSEARCA:CLDI - American Stock Exchange - US3207033099 - Common Stock

0.764  -0.07 (-8.46%)

After market: 0.8118 +0.05 (+6.26%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CLDI revenue by date.CLDI revenue by date.
449K45K
-89.98%
-100.00%		15.3M30.6M
100.00%		63.24M
106.67%
EBITDA
YoY % growth
CLDI ebitda by date.CLDI ebitda by date.
-6.666M-9.45M
-41.76%		-22.868M
-141.99%		N/A
-25.07%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CLDI ebit by date.CLDI ebit by date.
-6.773M-9.606M
-41.83%		-23.128M
-140.77%		-27.13M
-25.35%		-23.437M
19.16%		-26.159M
-11.62%		-28.484M
-8.89%		-31.179M
-9.46%		-35.178M
-12.82%		-22.437M
36.22%		-2.914M
87.01%		17.434M
698.26%
Operating Margin
CLDI operating margin by date.CLDI operating margin by date.
N/A-2,139.42%-51,395.56%N/AN/AN/AN/AN/AN/A-146.65%-9.52%27.57%
EPS
YoY % growth
CLDI eps by date.CLDI eps by date.
N/AN/AN/A-14.28-4.05
71.64%		-0.92
77.20%		-0.73
20.44%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.38
92.12%		-0.25
87.30%		-0.21
85.06%		-0.21
67.20%		-0.22
41.51%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.458M
44.42%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.65
53.57%		-0.870.2225.47%
Q2 2024
Q2Q % growth		 -1.40 -1.460.064.02%
Q1 2024
Q2Q % growth		 -2.00 -2.810.8128.70%
Q4 2023
Q2Q % growth		 -4.80 -2.09-2.71-129.56%
Q3 2023
Q2Q % growth		 -1.40 -1.730.3319.26%
CLDI Yearly EPS VS EstimatesCLDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -5 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CLDI Yearly Revenue VS EstimatesCLDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 20.12%
RevenueN/A N/A N/A N/A